At a time when there are no rules or regulations for online selling of medicines have been framed and several cases are pending in various courts, e-pharmacies have started working illegally. Gujarat State Pharmacy Council (GSPC) has suspended the registrations of two pharmacists for five years and imposed fine. For the First time in India such strong action has been initiated against e-pharmacies for violating rule 8 & 9 of Pharmacy Practice Regulation Act.
All India Organisation Of Chemists & Druggists (AIOCD) highlights data security issues with ePharmacy and their rules are not observed in draft guidelines of ePharmacy. A Meeting was called on 27th Aug, 2019 between AIOCD, state pharmacy associations and Mr. Mansukh L. Mandaviya, Minister of State for Chemicals and Fertilizers discuss issues relating to data security in E- Pharmacy.
Union Minister for Chemicals and Fertilizers, Shri D.V. Sadananda Gowda launched a mobile application “Janaushadhi Sugam” which will enable people to search Janaushadhi generic medicines and the stores at the tip of their fingers.
The Union Cabinet, chaired by the Prime Minister Shri Narendra Modi has approved signing of agreement between the National Medicinal Plants Board, Ministry of AYUSH of the Republic of India and the National Institute of Health of the Ministry of Health of the Republic of Peru on Cooperation in the field of Medicinal Plants.
Pharmacy council of India (PCI) proposed health ministry and stakeholders to include the post of Clinical Pharmacist with qualification, duties and responsibilities in hospital at 107th Central Council meeting held in August 2019. PCI decided to initiate action for amendment of the Pharmacy Practice Regulations, 2015 by incorporating the details of Position Title and job responsibilities in respect of Clinical Pharmacists.
“The Health Ministry has drawn an ambitious plan under the 100-days agenda of the newly elected government, wherein it has been decided to provide Rotavirus vaccine to every child across all 36 states and UTs by September, 2019.” This was stated by Dr Harsh Vardhan, Union Minister of Health and Family Welfare while speaking on the expansion of Rotavirus vaccine to the entire country. The Union Health Minister further added that under the inspirational leadership of our beloved Prime Minister Shri Narendra Modi ji, the Government is committed to ending morbidity and mortality in children due to diarrhoea by 2022. Strengthening routine immunization is an essential investment in India’s children and will ensure a healthy future of the country, he stressed.
“The National Medical Commission Act 2019 passed by both Houses of Parliament is historic and path-breaking. It is a huge and visionary reform in the medical education sector by the NDA Government under the leadership of our visionary Prime Minister Shri Narendra Modiji, and will prove to be a milestone in the years to come”. This was stated here today by Dr. Harsh Vardhan, Union Minister of Health & Family Welfare while addressing media persons on the NMC Act 2019. The Union Health Minister further said that “I am extremely grateful to the Hon’ble Prime Minister under whose strong leadership the National Medical Commission Act has finally seen the light of the day”.
Pharmaceutical Companies which introduced 22 drugs without prior approval of the National Pharmaceutical Pricing Authority (NPPA) have been issued notices by Government. The NPPA regularly takes action against such companies as per provisions of the Drugs (Prices Control) Order, 2013 (DPCO) which has been issued under the Essential Commodities Act, 1955.
The National Health Policy 2017 had defined the vision of ‘health and wellbeing for all at all ages’. Continuum of Care is a concept strongly advocated by the Policy. These lofty ideals are sought to be achieved by refactoring the existing schemes and introducing several new schemes including some digital initiatives.
As per government report, patients have saved Rs. 12,447 crores after Price Fixation of Essential Medicines by National Pharmaceutical Pricing Authority (NPPA). NPPA is an independent Regulator for pricing of drugs and to ensure availability and accessibility of medicines at affordable prices.